RN7SL110P

Across TCGA pan-cancer cohorts, RN7SL110P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL110P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RN7SL110P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL110P expression acts as an unfavorable survival marker.

ESCA, LUAD, and BLCA are the cancer types where RN7SL110P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.353	0.537	.007	84	view →
LUAD	DFS	Tertile	IV	0.448	0.936	<.001	54	view →
BLCA	OS	Tertile	IV	0.052	0.575	<.001	36	view →
UCEC	OS	Tertile	All	0.697	0.877	.021	36	view →
SARC	DFS	Tertile	All	0.146	0.611	<.001	30	view →
ACC	OS	Tertile	IV	0.145	0.715	<.001	27	view →
STAD	DFS	Tertile	All	0.553	0.748	.012	21	view →
SKCM	DFS	Tertile	IV	0.038	0.472	<.001	18	view →
LIHC	DFS	Tertile	All	0.255	0.560	.017	18	view →
COAD	OS	Tertile	All	0.259	0.688	.021	15	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL110P–ESCA (DFS)

Open the ESCA breakdown →